Form Type:  424B3
Filing Date:  12/2/2022 
CIK:  0001860657 
Address:  24 SCHOOL ST., 2ND FLOOR 
City, State, Zip:  BOSTON, Massachusetts 02108 
Telephone:  401-426-4664 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
-0.019 (-7.28%)  
Trade Time: 
02:31 PM EST  
Market Cap: 
Trade ALLR now with

© 2023  
Description of Business
We are a clinical stage biopharmaceutical company targeting some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates together with our proprietary DRP® companion diagnostics in a precision medicine approach. Our business strategy includes a focus on leveraging our proprietary DRP® companion diagnostics platform to streamline the drug development process and to identify patients that will benefit from therapeutic candidates that other biotechnology or pharmaceutical companies have abandoned or shelved after initiating clinical trials under an IND application filed with the FDA, including candidates that have failed to achieve statistical significance on the original endpoints established in their clinical trials.
Register and access this filing in:     
  FORM 424B3
    Item 9.01. Financial Statements and Exhibits.

EDGAR® and SEC® are trademarks of the U.S. Securities and Exchange Commission. OTC Markets Group Inc.'s products and services are not affiliated with or approved by the U.S. Securities and Exchange Commission.